anti-F1 capsid mAb (NCI/USAMRD)

N/A

Report date: 2025/03/17 20:00:36

Base Information

Drug Nameanti-F1 capsid mAb (NCI/USAMRD)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionF1 capsule antigen modulators
TargetsF1 capsule antigen
Therapy Area/IndicationsPlague
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthNational Cancer InstituteUS Army Medical Research Institute of Infectious Diseases
Active IndicationsN/A
Inactive IndicationsPlague

Other Information

ATC CodeN/A
Related LinksN/A